Operating Lease, Right-of-Use Asset of Outlook Therapeutics, Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Outlook Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Outlook Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $225,508, a 18% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Outlook Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $225,508 -$49,137 -18% 30 Sep 2025 10-K 19 Dec 2025 2025 FY
Q2 2025 $238,266 -$48,196 -17% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q3
Q1 2025 $250,699 +$246,960 +6605% 31 Mar 2025 10-Q 15 May 2025 2025 Q2
Q4 2024 $262,822 +$247,866 +1657% 31 Dec 2024 10-Q 14 Feb 2025 2025 Q1
Q3 2024 $274,645 +$248,473 +949% 30 Sep 2024 10-K 19 Dec 2025 2025 FY
Q2 2024 $286,462 +$249,073 +666% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q3
Q1 2024 $3,739 -$44,842 -92% 31 Mar 2024 10-Q 15 May 2024 2024 Q2
Q4 2023 $14,956 -$44,626 -75% 31 Dec 2023 10-Q 14 Feb 2024 2024 Q1
Q3 2023 $26,172 -$44,188 -63% 30 Sep 2023 10-K 27 Dec 2024 2024 FY
Q2 2023 $37,389 -$43,535 -54% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q3
Q1 2023 $48,581 -$42,708 -47% 31 Mar 2023 10-Q 15 May 2023 2023 Q2
Q4 2022 $59,582 -$41,886 -41% 31 Dec 2022 10-Q 14 Feb 2023 2023 Q1
Q3 2022 $70,360 -$41,069 -37% 30 Sep 2022 10-K 22 Dec 2023 2023 FY
Q2 2022 $80,924 -$40,273 -33% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q3
Q1 2022 $91,289 31 Mar 2022 10-Q 13 May 2022 2022 Q2
Q4 2021 $101,468 -$25,308 -20% 31 Dec 2021 10-Q 14 Feb 2022 2022 Q1
Q3 2021 $111,429 -$55,557 -33% 30 Sep 2021 10-K 29 Dec 2022 2022 FY
Q2 2021 $121,197 -$85,032 -41% 30 Jun 2021 10-Q 13 Aug 2021 2021 Q3
Q4 2020 $126,776 -$155,331 -55% 31 Dec 2020 10-Q 16 Feb 2021 2021 Q1
Q3 2020 $166,986 30 Sep 2020 10-K 23 Dec 2021 2021 FY
Q2 2020 $206,229 30 Jun 2020 10-Q 14 Aug 2020 2020 Q3
Q1 2020 $244,600 31 Mar 2020 10-Q 15 May 2020 2020 Q2
Q4 2019 $282,107 31 Dec 2019 10-Q 14 Feb 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.